Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis

被引:39
作者
Bras-Gonçalves, RA
Pocard, M
Formento, JL
Poirson-Bichat, F
De Pinieux, G
Pandrea, I
Arvelo, F
Ronco, G
Villa, P
Coquelle, A
Milano, G
Lesuffleur, T
Dutrillaux, B
Poupon, MF
机构
[1] Inst Curie, CNRS, UMR 147, Lab Cytogenet Mol & Oncol, F-75231 Paris 05, France
[2] Ctr Rech Biomed Cordeliers, Lab Metab & Differenciat Intestinale, Paris, France
[3] Cent Univ Caracas, Fac Sci, Caracas, Venezuela
[4] Fac Sci, Lab Chim Organ & Cinet, Amiens, France
关键词
D O I
10.1053/gast.2001.22440
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Butyrate, produced in the colon lumen, maintains mucosal cell homeostasis, Poorly diffusible, its access is compromised in growing colon cancers and absent in distant metastases. Butyrate regulates DNA synthesis, We postulated that systemic administration of butyrate should reduce colon cancer growth and enhance 5-fluorouracil (5-FU) efficacy, Methods: A stable derivative of butyrate (Bn-But) was used, The antitumoral efficacy of 5-FU and 3n-But, alone or combined, was evaluated in human colorectal cancers (hCRCs) subcutaneously, orthotopically, or intrasplenically grafted into nude mice, Thymidylate synthase (TS) and thymidine kinase (TH) mRNA expression, proliferation, apoptosis, and cell cycle alterations were studied, Results: In vivo, 5-FU alone inhibited growth of only 3 of the 12 hCRCs tested and Bn-But alone had no effect; the 5-FU/3n-But combination inhibited growth of all 16 hCRCs tested. The hCRCs differed in their p53 and microsatellite instability status. 5-FU/3n-But decreased TH and TS mRNA expression by 20- and 40-fold, respectively, and TS activity by 75%, stopped cell proliferation without affecting cell differentiation, and significantly enhanced apoptosis. 3n-But potentiated the efficacy of Tomudex and methotrexate, 2 TS inhibitors, but not that of oxaliplatin, In vitro, 5-FU/3n-But inhibited [H-3]thymidine but not bromodeoxyuridine incorporation and induced apoptosis in hCRC cell lines. Cells treated with 5-FU/Bn-But did not accumulate in G(1) nor in S phase of the cell cycle, while 5-FU and 3n-But arrested the cycle in S and in G(1) phase, respectively, 3n-But prevented the cell rescue from 5-FU-induced cytotoxicity by uridine or thymidine, Conclusions: 3n-But and TS inhibitors acted synergistically against colorectal cancers, independently of the genetic alterations of the hCRCs, The mechanism of action of 5-FU/Bn-But could be enhanced reduction of TS and prevention of thymidine salvage in DNA synthesis.
引用
收藏
页码:874 / 888
页数:15
相关论文
共 55 条
  • [1] ACTIVITY OF THYMIDYLATE SYNTHETASE, THYMIDINE KINASE AND GALACTOKINASE IN PRIMARY AND XENOGRAFTED HUMAN COLORECTAL CANCERS IN RELATION TO THEIR CHROMOSOMAL PATTERNS
    BARDOT, V
    LUCCIONI, C
    LEFRANCOIS, D
    MULERIS, M
    DUTRILLAUX, B
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (05) : 670 - 674
  • [2] A ROLE FOR DIHYDROPYRIMIDINE DEHYDROGENASE AND THYMIDYLATE SYNTHASE IN TUMOR SENSITIVITY TO FLUOROURACIL
    BECK, A
    ETIENNE, MC
    CHERADAME, S
    FISCHEL, JL
    FORMENTO, P
    RENEE, N
    MILANO, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1994, 30A (10) : 1517 - 1522
  • [3] BOFFA LC, 1978, J BIOL CHEM, V253, P3364
  • [4] BOFFA LC, 1992, CANCER RES, V52, P5906
  • [5] Sensitivity to CPT-11 of xenografted human colorectal cancers as a function of microsatellite instability and p53 status
    Bras-Gonçalves, RA
    Rosty, C
    Laurent-Puig, P
    Soulié, P
    Dutrillaux, B
    Poupon, MF
    [J]. BRITISH JOURNAL OF CANCER, 2000, 82 (04) : 913 - 923
  • [6] BREITMAN TR, 1966, CANCER RES, V26, P2282
  • [7] Céraline J, 1998, INT J CANCER, V75, P432, DOI 10.1002/(SICI)1097-0215(19980130)75:3<432::AID-IJC17>3.0.CO
  • [8] 2-A
  • [9] Conty JL, 1997, REV ESP ENFERM DIG, V89, P813
  • [10] THYMIDYLATE SYNTHASE GENE AMPLIFICATION IN HUMAN COLON-CANCER CELL-LINES RESISTANT TO 5-FLUOROURACIL
    COPUR, S
    AIBA, K
    DRAKE, JC
    ALLEGRA, CJ
    CHU, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 49 (10) : 1419 - 1426